These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9786475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects.
    Stass H, Dalhoff A, Kubitza D, Schühly U.
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2060-5. PubMed ID: 9687407
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
    Gajjar DA, Bello A, Ge Z, Christopher L, Grasela DM.
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2256-63. PubMed ID: 12821477
    [Abstract] [Full Text] [Related]

  • 9. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
    Mant TG.
    Am J Med; 1992 Apr 06; 92(4A):26S-32S. PubMed ID: 1316066
    [Abstract] [Full Text] [Related]

  • 10. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
    Allen A, Bygate E, Vousden M, Oliver S, Johnson M, Ward C, Cheon A, Choo YS, Kim I.
    Antimicrob Agents Chemother; 2001 Feb 06; 45(2):540-5. PubMed ID: 11158752
    [Abstract] [Full Text] [Related]

  • 11. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
    Bron NJ, Dorr MB, Mant TG, Webb CL, Vassos AB.
    J Antimicrob Chemother; 1996 Dec 06; 38(6):1023-9. PubMed ID: 9023649
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1- piperazinyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid hydrochloride (DW-116), a new quinolone antibiotic in rats.
    Yu IL, Chung SJ, Lee MH, Shim CK.
    J Pharm Sci; 1997 May 06; 86(5):550-3. PubMed ID: 9145377
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and safety of single oral doses of lomefloxacin.
    Morse IS.
    Biopharm Drug Dispos; 1990 May 06; 11(6):543-51. PubMed ID: 2207304
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
    Wise R, Johnson J, O'Sullivan N, Andrews JM, Imbimbo BP.
    J Antimicrob Chemother; 1991 Dec 06; 28(6):905-9. PubMed ID: 1667783
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar 06; 47(3):276-84. PubMed ID: 9105546
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and tolerance of a new fluoroquinolone antimicrobial drug after single oral doses in healthy volunteers.
    Tanaka M, Tamura K, Atarashi S, Kubo Y, Oliver SD, Bentley M, Hakusui H.
    Xenobiotica; 1995 Nov 06; 25(10):1119-25. PubMed ID: 8578768
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
    Teng R, Harris SC, Nix DE, Schentag JJ, Foulds G, Liston TE.
    J Antimicrob Chemother; 1995 Aug 06; 36(2):385-94. PubMed ID: 8522468
    [Abstract] [Full Text] [Related]

  • 18. Effect of age and gender on the pharmacokinetics of grepafloxacin.
    Efthymiopoulos C, Bramer SL, Maroli A.
    Clin Pharmacokinet; 1997 Aug 06; 33 Suppl 1():9-17. PubMed ID: 9433651
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
    Morrison PJ, Mant TG, Norman GT, Robinson J, Kunka RL.
    Antimicrob Agents Chemother; 1988 Oct 06; 32(10):1503-7. PubMed ID: 3214495
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
    Mattina R, Bonfiglio G, Cocuzza CE, Gulisano G, Cesana M, Imbimbo BP.
    Chemotherapy; 1991 Oct 06; 37(6):389-97. PubMed ID: 1662127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.